With more than seven million daily users on the HotCopper forums, each and every discussion can move markets. That’s why getting in front of those red-hot trends is key for every trader worth their salt. In this daily HotCopper Trends column, we break down the top Oz stocks through each trading day.
Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.
The leader for the day: Global miner Lodestar Resources (ASX:LSR) has attracted a strong following on the HotCopper forums after receiving firm commitments to raise approximately $4.4 million to advance a range of projects.
Funds will go towards exploration of large-scale copper targets in Chile, high-grade heavy rare earth exploration in the U.S. and advancing the Ned’s Creek gold project in Western Australia. The raising attracted a good percentage of “skin in the game” with directors committing a total of $305,700.
Lodestar has a three-pronged approach to propelling its portfolio, including high-impact copper exploration at the Three Saints IOCG project and Los Loros copper-molybdenum-gold porphyry asset in Chile.
Despite the interest, LSR has been down -8.33%.
Elsewhere, Minbos Resources (ASX:MNB) has taken off on the news that it signed the final security agreement required under the company’s US$16M loan facility with the Industrial Development Corporation of South Africa.
The signing marks the completion of the key steps required before drawdown under the IDC facility to help support the company’s Cabinda project in Angola. The first drawdown will help cover activities such as mobilisation costs for the phase two construction contract, valued at approximately US$13.8 million.
MNB was up +66.7%, to 2.5¢ at the time of writing today.
Meanwhile, clinical-stage biotech company Neurizon Therapeutics (ASX:NUZ) has obtained the go-ahead to increase the size of regimen one of the Healey ALS platform trial. The numbers are up significantly, with the total patient cohort growing from 160 to 240 participants after this update.
The expansion was driven by the enrolment rate exceeding original expectations and the absence of a concurrent regimen during the expected recruitment period.
Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS.
NUZ up +8%, to 6.7¢.
Wider, after starting slowly on the back of further unrest in the Middle East, the S&P/ASX 200 gained 17.30 points or +0.2%, to 8,675.10 at the time of going to press, despite crossing below its 20D average.
Local punters perked up after the consumer price index (CPI) rose 4.2% in the 12 months to April 2026, according to data from the ABS.
The CPI was down from the 4.6% annual inflation reported in March.
That’s Wednesday’s HotCopper Market Trends, I’m Colin Sandell-Hay - see you for close.
Join the discussion. See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.